Latest news
Gonorrhoea Is Learning To Beat Ceftriaxone. Europe Must Move First.
Ceftriaxone-resistant gonorrhoea is no longer only being imported into Europe. ECDC has found evidence of domestic transmission. The window to keep first-line treatment effective is still open, but it will close if testing and follow-up remain optional
MENA’s cardiometabolic crisis is a stability issue
IPM Brief – Issue 10 | Proof Is Not Access
The Transplant Is Not the Finish Line
For Pompe Infants, Time Is the Comparator
Alzheimer’s Trials Still Measure Too Little, Too Late
Mpox Reached Guinea-Bissau. Stigma Must Not Win.
The Most Preventable Cause of Vision Loss May Still Be Smoking
Global cardiovascular policy shifts accelerate, but diverging strategies expose uneven progress
Corxel’s oral GLP-1 trial adds momentum. The real question is who these drugs will reach
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.